scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S0360-3016(02)04576-5 |
P698 | PubMed publication ID | 12654444 |
P2093 | author name string | Pauline T Truong | |
Jan Lim | |||
Mary Lesperance | |||
Howard Joe | |||
Heidi Martins | |||
Mary V MacNeil | |||
Adam Webber | |||
Joanna J S Ludbrook | |||
P2860 | cites work | Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis | Q24800321 |
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation | Q29547376 | ||
Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 | ||
Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study | Q33501796 | ||
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group | Q33870498 | ||
Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base | Q33934669 | ||
Treatment and outcomes for elderly patients with small cell lung cancer | Q34067406 | ||
Influence of age and comorbidities on the chemotherapeutic management of lung cancer | Q34384478 | ||
Retrospective review of chemotherapy for small cell lung cancer in the elderly: does the end justify the means? | Q36461621 | ||
Treatment of small cell lung cancer in the elderly | Q40798998 | ||
A meta-analysis of thoracic radiotherapy for small-cell lung cancer | Q41086687 | ||
Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis | Q45371243 | ||
Similar outcome of elderly patients in intergroup trial 0096: Cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma | Q46242749 | ||
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group | Q48341719 | ||
Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients. | Q52867345 | ||
Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. | Q53598860 | ||
Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission | Q57665429 | ||
Influence of age on the treatment of limited-stage small-cell lung cancer | Q59647379 | ||
Treatment of small cell lung carcinoma in the elderly | Q71102123 | ||
Underrepresentation of patients 65 years of age or older in cancer-treatment trials | Q73311140 | ||
Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European | Q74202008 | ||
Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer | Q77435853 | ||
Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide | Q77912158 | ||
Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer | Q77957625 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | comorbidity | Q1414874 |
P304 | page(s) | 1321-1330 | |
P577 | publication date | 2003-04-01 | |
P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
P1476 | title | Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis | |
P478 | volume | 55 |
Q36614935 | A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index |
Q37392175 | Assessment of health status in elderly patients with cancer |
Q36552519 | Barriers to accessing radiation therapy in Canada: a systematic review. |
Q33798652 | Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III |
Q47362756 | Can weight loss at presentation predict patient outcome in lung cancer? |
Q39753118 | Characteristics of patients and predictors of in-hospital mortality after hospitalization for head and neck cancers |
Q46601897 | Chemoradiotherapy for locally advanced pancreatic carcinoma in elderly patients |
Q43529176 | Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it? |
Q47679773 | Comorbidity Profiles of Patients with Lung Cancer: A New Approach to Risk Stratification? |
Q40612067 | Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer |
Q58574211 | Compliance and outcome of elderly patients treated in the Concurrent ONce daily VErsus twice-daily RadioTherapy (CONVERT) trial |
Q41380574 | Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial |
Q36439424 | Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: A population-based propensity-score matched analysis |
Q38608627 | Current challenges of lung cancer care in an aging population |
Q34266302 | Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes |
Q73166784 | Do "elderly fit" patients have less comorbidity? |
Q44509853 | Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer |
Q39814474 | Health behaviors and demographic factors of chronic health conditions among elderly veteran men. |
Q35208186 | How do patient and hospital features influence outcomes in small-cell lung cancer in England? |
Q40049755 | Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old. |
Q36967155 | Modern management of small-cell lung cancer |
Q38451808 | No improvement in lung cancer care: the management of lung cancer in 1996 and 2002 in New South Wales. |
Q50050610 | Prognostic factors and survival of patients with small cell lung cancer in a northeastern Chinese population |
Q33625372 | Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. |
Q38002472 | Prophylactic cranial irradiation for small-cell lung cancer: how, when and for whom? |
Q57495396 | Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes |
Q37614574 | Radiochemotherapy in the elderly with lung cancer. |
Q35107298 | Small-cell lung cancer in England: trends in survival and chemotherapy using the National Lung Cancer Audit |
Q51656955 | Survival and prognostic factors in small cell lung cancer. |
Q40508047 | The Younger Patients Have More Better Prognosis in Limited Disease Small Cell Lung Cancer |
Q83352619 | The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002 |
Q33994360 | The role of patient, tumour and system factors in socioeconomic inequalities in lung cancer treatment: population-based study |
Q30830775 | The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study |
Q36715266 | Tolerance to chemotherapy in elderly patients with cancer |
Q37723646 | Treatment of small cell lung cancer in academic and community settings: factors associated with receiving standard therapy and survival |
Q37677010 | Treatment of small-cell lung cancer in elderly patients |
Q38068403 | Uptake and tolerance of chemotherapy in elderly patients with small cell lung cancer and impact on survival |
Q37783975 | Utilization of prophylactic cranial irradiation in patients with limited stage small cell lung carcinoma. |
Q83308902 | Whole-body metabolic tumour volume of 18F-FDG PET/CT improves the prediction of prognosis in small cell lung cancer |
Search more.